12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Dare Bioscience (DARE) led the gainers with a 31.1% increase, while Phio Pharma (PHIO) saw the largest decline, dropping 34%. Other notable movers included Anixa Biosciences (ANIX), Vanda Pharma (VNDA), and Cerevel Therapeutics Hldg (CERE) with substantial gains, and Modular Medical (MODD) and WAVE Life Sciences (WVE) with notable losses.
December 07, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Anixa Biosciences shares increased by 20.35% to $4.73, with a market cap of $146.9 million.
The pre-market gain for ANIX suggests positive developments or investor confidence that could lead to a short-term uptrend.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cerevel Therapeutics Hldg shares rose 14.54% to $42.3, with a market cap of $7.6 billion.
CERE's pre-market increase could be driven by investor optimism or positive news, which may result in a short-term bullish trend for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Dare Bioscience shares jumped 31.1% in pre-market trading with a market cap of $44.8 million.
The substantial pre-market gain for DARE indicates positive investor sentiment which could lead to a short-term price increase if the momentum continues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Vanda Pharma stock rose 20.04% to $4.85, with a market cap of $279.0 million.
The significant rise in VNDA's pre-market trading could be due to favorable news or investor sentiment, possibly leading to a short-term positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Modular Medical shares declined by 27.47% to $1.03, with a market cap of $21.8 million.
The sharp decline in MODD's pre-market trading suggests negative investor sentiment or adverse news, which could negatively affect the stock in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Phio Pharma stock saw a sharp decline of 34% in pre-market trading with a market cap of $2.5 million.
The significant pre-market drop for PHIO could reflect negative news or investor sentiment, potentially leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
WAVE Life Sciences shares decreased by 22.57% to $5.32, with a market cap of $526.9 million.
WVE's pre-market drop could indicate underlying issues or negative sentiment, potentially leading to further short-term depreciation in stock value.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100